To compare Tramadol and Dexmedetomidine in the treatment of shivering after spinal anaesthesia

Comparison of tramadol and dexmedetomidine in treatment of post neuraxial anaesthesia shivering

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012732

Enrollment

100

Registered

2018-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA I and II

Interventions

Intervention1: Tramadol: To control Post spinal anaesthesia shivering within 10 minutes Control Intervention1: Dexmedetomidine: To control Post spinal anaesthesia shivering within 10 minutes and compa

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA Grade I and II 2. Patients admitted for lower abdominal and lower limb surgeries

Exclusion criteria

Exclusion criteria: 1. Patients with cardiopulmonary disease, hepatic disorder, respiratory and neurological disorder. 2. Allergy to the study drugs 3. Those with an initial heart rate 4. Systolic blood pressure 5. Patient on narcotics or any other sedatives which alter the thermoregulation 6. Patients with recent history of febrile illness and those with history of malignant hyperthermia. 7. Contraindication to regional anaesthesia

Design outcomes

Primary

Measure	Time frame
control of shiveringTimepoint: 5 minutes	—

Secondary

Measure	Time frame
Recurrence of shiveringTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Abhilekh Jain

Peoples College of Medical Sciences and Research Centre

jainabhilekh@rediffmail.com9827606268

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026